纤维素
化学
纳米晶
化学工程
肠道菌群
纳米技术
纳米颗粒
细菌纤维素
原材料
细菌
傅里叶变换红外光谱
生物相容性
材料科学
催化作用
作者
Gang Long,Bowen Jia,Xuefei Chen,Yunfei Shen,Guojun Jin,Hou-Yong Yu,Jia-Fu Zhu
标识
DOI:10.1021/acssuschemeng.6c01041
摘要
The clinical application of cellulose nanocrystals (CNCs) as pharmaceutical excipients has been hindered by the low yields (<50%) of traditional acid hydrolysis and unclear comprehensive safety evaluations regarding the gut microbiota. Herein, we report a green mechanochemical synergistic strategy utilizing l -malic acid ( l -MA)-assisted high-shear hydrolysis to overcome these bottlenecks. This process achieved an exceptional yield of 91.51% while endowing the CNCs with high crystallinity (80.16%) and abundant surface carboxyl groups via in situ esterification. When employed as a direct compression excipient, the CNCs formed a unique “interlocking inlay” microstructure, resolving the long-standing trade-off between tablet hardness and disintegration. The resulting tablets exhibited more superior hardness (>29 N) and minimal friability (<0.31%) than commercial microcrystalline cellulose and starch, yet achieved ultrarapid disintegration (∼3 s) driven by enhanced hydrophilicity and capillary action. Furthermore, life cycle assessment (LCA) demonstrated significant reductions in carbon footprint and energy consumption. Crucially, an in vitro gut microbiota model confirmed the biological safety of the CNCs, showing no adverse effects on the growth kinetics of core intestinal bacteria. This work provides a sustainable, scalable paradigm for next-generation pharmaceutical excipients.
科研通智能强力驱动
Strongly Powered by AbleSci AI